Downregulation of KRAB zinc finger proteins in 5-fluorouracil resistant colorectal cancer cells

Abstract excerpt

Radio-chemotherapy with 5-flu orouracil (5-FU) is the standard of care treatment for patients with colorectal cancer, but it is only effective for a third of them. Despite our understanding of the mechanism of action of 5-FU, drug resistance remains a significant limitation to the clinical use of 5-FU, as both intrinsic and acquired chemoresistance represents the major obstacles for the success of 5-FU-based...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to DNA Repair Mechanisms
• Share to Drug Transport and Resistance Mechanisms
• Share to Genomics and Chromatin Dynamics